HRP950142A2 - Inhaler - Google Patents

Info

Publication number

HRP950142A2

HRP950142A2 HRP-252/92A HRP950142A HRP950142A2 HR P950142 A2 HRP950142 A2 HR P950142A2 HR P950142 A HRP950142 A HR P950142A HR P950142 A2 HRP950142 A2 HR P950142A2

Authority

HR

Croatia

Prior art keywords

dosing

housing

inhaler according

significant

supply chamber

Prior art date

1991-03-21

Links

• Espacenet
• Global Dossier
• Discuss

• 239000000843 powder Substances 0.000 claims description 42
• 239000000203 mixture Substances 0.000 claims description 21
• 239000000126 substance Substances 0.000 claims description 20
• 238000009415 formwork Methods 0.000 claims description 17
• 239000007787 solid Substances 0.000 claims description 15
• 239000011435 rock Substances 0.000 claims description 13
• 238000006243 chemical reaction Methods 0.000 claims description 12
• 230000035939 shock Effects 0.000 claims description 10
• 241000167854 Bourreria succulenta Species 0.000 claims description 5
• 230000001088 anti-asthma Effects 0.000 claims description 5
• 235000019693 cherries Nutrition 0.000 claims description 5
• 238000006073 displacement reaction Methods 0.000 claims description 5
• 210000000056 organ Anatomy 0.000 claims description 5
• 230000009467 reduction Effects 0.000 claims description 5
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 4
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
• 239000000924 antiasthmatic agent Substances 0.000 claims description 4
• 239000002274 desiccant Substances 0.000 claims description 4
• BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 claims description 4
• 229960002848 formoterol Drugs 0.000 claims description 4
• 239000008101 lactose Substances 0.000 claims description 4
• 230000000630 rising effect Effects 0.000 claims description 4
• 230000009466 transformation Effects 0.000 claims description 4
• 230000006835 compression Effects 0.000 claims description 3
• 238000007906 compression Methods 0.000 claims description 3
• 230000000994 depressogenic effect Effects 0.000 claims description 3
• 238000003780 insertion Methods 0.000 claims description 2
• 230000037431 insertion Effects 0.000 claims description 2
• 230000004888 barrier function Effects 0.000 claims 1
• 230000007306 turnover Effects 0.000 claims 1
• 239000002775 capsule Substances 0.000 description 22
• 206010011224 Cough Diseases 0.000 description 7
• 230000000903 blocking effect Effects 0.000 description 5
• 238000010276 construction Methods 0.000 description 5
• 238000003825 pressing Methods 0.000 description 5
• 210000003813 thumb Anatomy 0.000 description 5
• 230000009471 action Effects 0.000 description 4
• 230000004526 pharmaceutical effect Effects 0.000 description 4
• 208000006673 asthma Diseases 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 230000007423 decrease Effects 0.000 description 3
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 230000000694 effects Effects 0.000 description 2
• 230000005484 gravity Effects 0.000 description 2
• 230000001681 protective effect Effects 0.000 description 2
• 238000010926 purge Methods 0.000 description 2
• 230000029058 respiratory gaseous exchange Effects 0.000 description 2
• 210000002345 respiratory system Anatomy 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 239000000741 silica gel Substances 0.000 description 2
• 229910002027 silica gel Inorganic materials 0.000 description 2
• 230000007704 transition Effects 0.000 description 2
• OBRNDARFFFHCGE-PERKLWIXSA-N (S,S)-formoterol fumarate Chemical class OC(=O)\C=C\C(O)=O.C1=CC(OC)=CC=C1C[C@H](C)NC[C@@H](O)C1=CC=C(O)C(NC=O)=C1.C1=CC(OC)=CC=C1C[C@H](C)NC[C@@H](O)C1=CC=C(O)C(NC=O)=C1 OBRNDARFFFHCGE-PERKLWIXSA-N 0.000 description 1
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
• 206010044565 Tremor Diseases 0.000 description 1
• 230000004323 axial length Effects 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 150000004683 dihydrates Chemical class 0.000 description 1
• 239000000428 dust Substances 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 230000002427 irreversible effect Effects 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 230000010355 oscillation Effects 0.000 description 1
• 230000000149 penetrating effect Effects 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• 230000036316 preload Effects 0.000 description 1
• 238000007789 sealing Methods 0.000 description 1
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
• 238000005406 washing Methods 0.000 description 1